For procurement managers in the pharmaceutical industry, securing a consistent and reliable supply of high-quality intermediates is fundamental to successful drug manufacturing. When focusing on SGLT2 inhibitors, such as Ipragliflozin, Empagliflozin, and Dapagliflozin, understanding the essential precursors is vital. Among these, 2,3,4,6-Tetra-O-benzyl-D-gluconic acid lactone (CAS: 13096-62-3) stands out as a critical component.

This lactone is an advanced intermediate used in the synthesis of compounds that target type 2 diabetes mellitus. Its complex structure, derived from glucose, requires specialized manufacturing processes to ensure high purity and consistent batch-to-batch quality. As a leading pharmaceutical intermediate supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. understands the stringent requirements of API manufacturing. We are dedicated to providing intermediates like this lactone derivative with guaranteed purity of ≥95.0%.

When considering where to purchase 2,3,4,6-Tetra-O-benzyl-D-gluconic acid lactone, it’s important to evaluate potential suppliers based on their manufacturing capabilities, quality control systems, and supply chain reliability. Engaging with a reputable manufacturer ensures that you receive materials that meet all regulatory and quality standards, minimizing risks in your production pipeline. Competitive price structures are also a key consideration for cost-effective manufacturing.

We aim to simplify the procurement process for essential chemicals. If your company is involved in the development or production of SGLT2 inhibitors, we invite you to request a quotation for this vital intermediate. Our commitment is to support your strategic sourcing needs by offering dependable access to critical pharmaceutical raw materials. Let us be your trusted partner in building a robust and efficient supply chain for advanced diabetes therapeutics.